Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
Public ClinicalTrials.gov record NCT00847899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Exploratory, 28-Day Study to Examine the Effects of AR9281 on Blood Pressure and Glucose Tolerance in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of AR9281, a novel s-EH enzyme inhibitor, in improving glucose metabolism and blood pressure in patients with impaired glucose tolerance and mild to moderate hypertension.
Study identification
- NCT ID
- NCT00847899
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2009 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Nov 2009 (Actual)
- Last update posted
- Nov 20, 2009
2009
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arete Investigational site | Mobile | Alabama | 36617 | — |
| Arete Investigational site | Muscle Shoals | Alabama | 35662 | — |
| Arete Investigational site | Anaheim | California | 92801 | — |
| Arete Investigational site | Concord | California | 94520 | — |
| Arete Investigational site | Mission Hills | California | 91345 | — |
| Arete Investigational site | Bradenton | Florida | 34203 | — |
| Arete Investigational site | DeLand | Florida | 32720 | — |
| Arete Investigational site | Jacksonville | Florida | 32216 | — |
| Arete Investigational site | Largo | Florida | 33770 | — |
| Arete Investigational site | Miami | Florida | 33169 | — |
| Arete Investigational site | New Port Richey | Florida | 34652 | — |
| Arete Investigational site | Pembroke Pines | Florida | 33026 | — |
| Arete Investigational site | Port Orange | Florida | 32127 | — |
| Arete Investigational site | Tampa | Florida | 33606 | — |
| Arete Investigational site | Marietta | Georgia | 30066 | — |
| Arete Investigational site | Addison | Illinois | 60101 | — |
| Arete Investigational site | Louisville | Kentucky | 40213 | — |
| Arete Investigational site | Brockton | Massachusetts | 02301 | — |
| Arete Investigational site | Paw Paw | Michigan | 49079 | — |
| Arete Investigational site | Las Vegas | Nevada | 89123 | — |
| Arete Investigational site | Cincinnati | Ohio | 45219 | — |
| Arete Investigational site | Cincinnati | Ohio | 45245 | — |
| Arete Investigational site | Marion | Ohio | 43302 | — |
| Arete investigational site | Mount Gilead | Ohio | 43338 | — |
| Arete Investigational site | Oklahoma City | Oklahoma | 73132 | — |
| Arete Investigational site | Eugene | Oregon | 97404 | — |
| Arete Investigational site | Austin | Texas | 78704 | — |
| Arete Investigational site | Dallas | Texas | 75251 | — |
| Arete Investigational site | San Antonio | Texas | 78229 | — |
| Arete Investigational site | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00847899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2009 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00847899 live on ClinicalTrials.gov.